Reuters logo
BRIEF-Compugen in process of developing therapeutic antibody for CGEN-15137/tigit
December 7, 2016 / 12:55 PM / 10 months ago

BRIEF-Compugen in process of developing therapeutic antibody for CGEN-15137/tigit

Dec 7 (Reuters) - Compugen Ltd:

* Compugen-In process of developing therapeutic antibody for cgen-15137/tigit, and expect to select lead antibody for this target by end of Q1 of 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below